The global apigenin market size was valued at USD 3.4 million in 2022 and is projected to reach a value of USD 5.4 million by 2031, registering a CAGR of 5.2% during the forecast period (2023-2031). Growing awareness of Apigenin's health advantages and an increase in its use in the pharmaceutical and nutraceutical industries will drive Apigenin market growth.
Apigenin is a flavone-class natural flavonoid, which is a form of polyphenolic substance. It is found in many plants, fruits, and vegetables, but it is especially plentiful in parsley, chamomile, onions, oranges, and celery. Apigenin has been examined for its diverse biological activities and is renowned for its potential health-promoting effects. Rising healthcare costs are expected to be a big industry driver. Individual healthcare difficulties are becoming increasingly common for various reasons, including bad lifestyle choices and poor cleanliness. Nonetheless, flavonoids benefit public health, and their increasing use in food processing promotes market growth.
However, the high initial costs associated with creating and maintaining a profitable company and the lack of knowledge and consciousness among various organizations for the coherent and economic advancement of these products are some of the variables expected to impede market expansion.
Consumers' growing awareness of Apigenin's potential health benefits, such as its antioxidant and anti-inflammatory qualities, may increase demand for goods containing this flavonoid. Consumer awareness is increased by research findings published in scholarly journals. For example, research shows Apigenin's antioxidant properties, anticancer activities, and anti-inflammatory characteristics.
Apigenin is becoming more popular as a dietary supplement or component in functional foods and beverages as people become more health-conscious and seek natural cures and supplements. The expanding corpus of research confirming Apigenin's health advantages is fueling market growth. According to a McKinsey & Company poll, 55% of consumers value healthy eating and 33% value sustainability. Furthermore, the global movement toward wellness and preventative Healthcare pushes people to seek natural substances linked to health promotion. As a result, the Apigenin market trend is projected to change throughout the forecast period.
Apigenin's poor clinical evidence for health benefits could be a commercial restriction. While there is promising preclinical research and some small-scale human trials, the degree of evidence for specific health claims may not be as substantial as required. Regulatory agencies, healthcare professionals, and consumers frequently seek well-established clinical evidence to support a compound's efficacy and safety. A substantial percentage of apigenin research may be in the preclinical stage, involving cell culture experiments and animal models. While these findings are informative, there may be a deficit in large-scale clinical trials. Apigenin is being researched for potential health advantages such as antioxidant, anti-inflammatory, and anticancer effects. However, given the scope of these claims, large-scale clinical trials to establish efficacy across different health issues may be required.
Apigenin's lack of clinical data may lead to a cautious attitude from both consumers and regulatory organizations. Manufacturers and marketers of apigenin-containing products may find difficulties making specific health claims without good clinical evidence. Furthermore, until more firm data is available, healthcare providers may hesitate to offer Apigenin.
Apigenin is a strong possibility due to the growing customer desire for natural and plant-based products. As customers become more health-conscious and ecologically conscientious, there is an increasing demand for natural-source products. According to insights given by the Good Food Institute (GFI) and the Plant Based Foods Association (PBFA) based on retail sales data commissioned from SPINS, the plant-based food market in the United States retail in 2022 will be valued at USD 8 billion, up 7% from 2021.
Similarly, according to a Nielsen survey, 48% of US customers actively seek natural products. Apigenin is favored by the clean label trend, in which consumers want openness in product content. Apigenin-containing products can be marketed as being clean, lightly processed, and free of synthetic ingredients. Furthermore, consumers are becoming increasingly worried about the environmental impact of their purchasing decisions. Plant-based compounds, such as Apigenin derived from botanicals, are regarded as more sustainable and environmentally friendly than synthetic counterparts.
| Study Period | 2019-2031 | CAGR | 5.2% |
| Historical Period | 2019-2021 | Forecast Period | 2023-2031 |
| Base Year | 2022 | Base Year Market Size | USD 3.4 Million |
| Forecast Year | 2031 | Forecast Year Market Size | USD 5.4 Million |
| Largest Market | North America | Fastest Growing Market | Asia Pacific |
The global apigenin market analysis is conducted in North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America.
North America is the most significant global apigenin market shareholder and is estimated to grow at a CAGR of 5.2% over the forecast period. Many chronic ailments in North America, such as type 2 diabetes, coronary heart disease, and obesity, can be avoided by modifying one's diet. This has increased the demand for nutritious products such as Apigenin. North America's pharmaceutical and nutraceutical industries have a well-established regulatory framework. Regulatory authorities in the region, such as the United States Food and Drug Administration (FDA) and Health Canada, give guidelines and approvals for using natural chemicals like Apigenin in various applications. This favorable regulatory environment benefits company statistics by assuring safety, quality, and adherence to industry norms.
Additionally, Dietary supplement use has increased dramatically in the United States during the last decade. Various studies have shown that by 2020, 75% of adults in the United States will have ingested dietary supplements, a 10% rise over the previous decade. Apigenin, renowned for its potential health advantages, could be employed in supplements that address various health and wellness issues. Furthermore, North American research institutions and pharmaceutical corporations may collaborate on initiatives examining Apigenin's therapeutic possibilities. Such collaborations may result in advancements in medication research and Healthcare. As a result, these variables are projected to influence the global Apigenin market share.
Asia-Pacific is anticipated to exhibit a CAGR of 5.3% over the forecast period. The Asia-Pacific region is expected to grow significantly, with China having the world's largest customer base for nutritional supplements and cosmetic items, competing with other countries, and stabilizing markets. In numerous regional economies, Apigenin demand in Asia-Pacific will be boosted by thriving pharmaceutical, nutraceutical, and dietary supplement businesses. Rising disposable incomes and changing lifestyles in the region have spurred the use of natural and plant-based components in various consumer products, including Apigenin. Traditional medical techniques in Asia-Pacific countries frequently include natural ingredients. Apigenin could be used in traditional formulations because of its possible health benefits. Furthermore, Asia Pacific's massive population and expanding middle class contribute to the region's market growth.
Europe has a moderate global market share, according to apigenin market insights. The emphasis on skincare and beauty among European customers may drive the usage of Apigenin in cosmetic and skincare products. Apigenin's antioxidant qualities may be accentuated in anti-aging or skin health products. According to a Cosmetics Europe survey, 72% of European consumers regard cosmetics and personal care products as "very important" in their everyday lives. Cosmetic items promote quality of life, boost self-esteem, and facilitate social connections, according to the major causes.
Furthermore, the European Union has stringent laws governing the usage of substances in various products. Compliance with these rules is critical for apigenin firms to assure product safety and meet legal obligations.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global apigenin market is segmented based on type, application, and region.
By Type, the market is further segmented into 0.95 And 0.98.
The 0.98 segment accounts for the largest share. This segment is most likely Apigenin with a purity or concentration of 98%. A higher purity level indicates that the apigenin component is more concentrated. Over the projection period, the 0.98 type segment is expected to increase rapidly. Apigenin's structural ability can efficiently absorb potentially damaging electrons in human systems, such as metal cations, reactive oxygen, nitrogen species, and reacting oxygen lifeforms. Apigenin has antioxidant properties and can be used in vitamins or cosmetics to prevent UV radiation and reactive chemicals from causing skin and DNA modifications and inflammatory illnesses.
A purity rating 0.95 suggests a high-quality product with a specified apigenin content. This purity level assures stability and dependability regarding active component content, which is critical for research, formulation, and product development. Apigenin, with a purity of 0.95, indicates that 95% of the component in a product or extract is pure Apigenin, with the remaining 5% containing additional chemicals, carriers, or contaminants.
The market can be bifurcated by application into Pharma and Healthcare, Food additives, Cosmetics, and Personal Care.
The pharma and Healthcare segment is a significant contributor to the market. Apigenin is used in the pharmaceutical and healthcare sectors in this segment. Linked to various health advantages, Apigenin could be employed in developing pharmaceutical medications, dietary supplements, and other healthcare items. Apigenin's anti-inflammatory, antioxidant and potentially therapeutic qualities may be investigated in pharma and Healthcare. It could be included in drugs, supplements, or therapy regimens for various health issues. The pharmaceutical and healthcare segment dominated the market. It will likely remain dominant in the coming years due to its characteristics for curing various healthcare disorders such as cancer and cardiovascular disease. Furthermore, increased Apigenin trials and research in the pharmaceutical and healthcare sectors will likely contribute to segment expansion.
Apigenin is used as a food additive in this segment. Apigenin may be added to food products to add flavor and color or to provide potential health advantages. Food additives are compounds added to food to improve its properties or increase its shelf life. Apigenin's natural qualities may be employed in food products, increasing antioxidant content or providing other functional benefits. It could be in drinks, sauces, or functional meals.
